Intratumoral induction of CD103 triggers tumor-specific CTL function and CCR5-dependent T-cell retention

Katarzyna Franciszkiewicz, Audrey Le Floc'h, Abdelali Jalil, Frédéric Vigant, Thomas Robert, Isabelle Vergnon, Andrzej Mackiewicz, Karim Benihoud, Pierre Validire, Salem Chouaib, Christophe Combadière, Fathia Mami-Chouaib

Research output: Contribution to journalArticlepeer-review

73 Scopus citations


We have reported previously that the interaction of α E(CD103)β7 integrin, expressed on a CD8+ tumor-infiltrating lymphocyte (TIL) clone but not on a peripheral blood lymphocyte (PBL) counterpart, with the epithelial marker E-cadherin on human lung tumor cells plays a crucial role in T-cell receptor-mediated cytotoxicity. We show here that both TIL and PBL clones are able to migrate toward autologous tumor cells and that chemokine receptor CCR5 is involved in this process. Adoptive transfer of the PBL clone in the cognate tumor engrafted in nonobese diabetic/severe combined immunodeficient mice and subsequent coengagement of T-cell receptor and transforming growth factor-β1 receptor triggers CD103 expression on T-cell surface resulting in strong potentiation of antitumor lytic function. Moreover, interaction of αEβ7 integrin with E-cadherin, but not lymphocyte function-associated antigen-1 with intercellular adhesion molecule-1, promotes CCR5 recruitment at the immunologic synapse formed between TIL and tumor cells, leading to inhibition of T-cell sensitivity to CCL5 chemotactic gradient. These results provide evidence for a role of tumor microenvironment, namely MHC class I-restricted antigen presentation and transforming growth factor-β1 secretion, in regulating the effector phase of tumor-specific CTL response. They also suggest a unique role of CD103 in T-cell retention at the tumor site by a CCR5-dependent mechanism.

Original languageEnglish
Pages (from-to)6249-6255
Number of pages7
JournalCancer Research
Issue number15
StatePublished - 1 Aug 2009
Externally publishedYes


Dive into the research topics of 'Intratumoral induction of CD103 triggers tumor-specific CTL function and CCR5-dependent T-cell retention'. Together they form a unique fingerprint.

Cite this